http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03101470-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a172f8dc781d98a6ff6512b2d9eff91d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f823c39145a31df71ddb011d0ff26b5d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b9835d6283f178ee548c3cd1e421d8fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2301c1b387990b156ac2bb362d52be41
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-202
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-202
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
filingDate 2003-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47336129bb7e558b9e04959da56cbf4b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6aae359a63bb0f9655ef89631f731ec2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5c48223709819c768dbef3f241e2857
publicationDate 2003-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-03101470-A1
titleOfInvention Pharmaceutical composition containing arsenic trioxide and at least one long-chain, polyunsaturated fatty acid
abstract The invention relates to pharmaceutical compositions that contain arsenic trioxide and at least one long-chain, polyunsaturated fatty acid. The invention further relates to the use of arsenic trioxide and at least one long-chain, polyunsaturated fatty acid for the therapeutic treatment of a malign degeneration, especially for the treatment of leukemia, promyelocytic leukemia, secondary resistant promyelocytic leukemia and/or primary resistant leukemia or for the treatment of a solid tumor such as a liver carcinoma or renal carcinoma.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9675574-B2
priorityDate 2002-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129211540
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395394
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID175542
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129547747
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107981
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3453
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127794012
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135002
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6253
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128178099

Total number of triples: 44.